Bardhaman, 11th June 2025: Suraksha Diagnostics has successfully launched its new centre in Bardhaman, occupying nearly 6,000 sq ft of area. The new centre features, the latest 3rd Generation MRI. For the first time all MRI investigations including Cardiac MRI, Neonatal MRI can be done in Burdwan now. Using it’s Cloud services, Suraksha Diagnostics will get the reports within 3 hours.
The centre also has an advanced USG system with 4D TVS. This will enable Suraksha Diagnostics to perform Anomaly scans with great precision. Foetal echocardiography services will also be available along with OPD Clinic facility, where some well-known specialists, including orthopaedists, neurologists, nephrologists, gastroenterologists, rheumatologists, and general medicine doctors, are available. Its OPD clinic facility caters to a wide ranging health concerns, offering an accessible and seamless way of receiving medical care services without getting hospitalised.
The biggest advantage is the Pathology Lab. Suraksha Diagnostics with it’s CAP accredited reference lab, will be able to provide all high end tests, including Genomic testing for the people of Burdwan. No one will have to travel to Kolkata any more for any Pathology tests. Home collection services are available as on date.
The launch of the new centre enhances the company’s presence in the state of West Bengal, giving access to the state-of-the-art diagnostic services to the people residing in Bardhaman. This will enable them to receive cost-effective and technologically advanced medical care services without needing to travel far.
With this new development, Suraksha Diagnostics has showcased its commitment to offering quality medical care services, revolutionising the way diagnostic services are provided in West Bengal. This ensures faster, more efficient, innovative delivery of diagnostic services, resulting in accurate detection and treatment of diseases and other conditions.
The inauguration event was graced by the presence of Abir Chatterjee, renowned Bengali actor, reflecting his commitment and responsibility towards enhancing the healthcare situation in Bardhaman. Dr. Somnath Chatterjee, Chairman and Joint Managing Director of Suraksha Diagnostics Ltd, Ritu Mittal, CEO and Managing Director of Suraksha Diagnostics Ltd also graced the occasion. Their strong presence further strengthened the impact of the launch event, ensuring the commitment of the team offering superior diagnostic services in Bardhaman and advancing the public healthcare scenario in the city.
Speaking on the launch of the new diagnostics centre in Bardhaman, Dr. Somnath Chatterjee, Chairman and Joint Managing Director of Suraksha Diagnostics Ltd stated: “We remain committed to the people of Burdwan to provide world class reports, ensuring quality at all points of time.”
Sharing her thoughts on the same, Ritu Mittal, CEO and Managing Director of Suraksha Diagnostics Ltd said: “We add a centre in the heart of Bengal in Burdwan. I am sure that in times to come this will prove to be of immense value to the people of Burdwan. We would try our best to prove that for investigations you do not have to travel anywhere, anymore.”
The launch of the new centre in Bardhaman by Suraksha Diagnostics ensures better and improved patient outcomes in the city with efficient planning of the treatment procedure. This will help to make informed decisions surrounding healthcare and to offer the appropriate care to patients with the aid of personalised healthcare packages. It also ensures early detection of chronic diseases, further expediting the recovery process, reducing treatment costs and chances of inaccuracies in the entire treatment process.
About Suraksha Diagnostics
Established in 1992, Suraksha Diagnostics has grown into a prominent diagnostics provider, offering a comprehensive range of over 2,300 tests across pathology, radiology, and medical consultancy services. The company operates a central reference laboratory, eight satellite laboratories, 59 diagnostic centres, and 166 sample collection centres across West Bengal, Bihar, Assam, and Meghalaya. Suraksha's commitment to technological advancement is evident in its adoption of AI-enabled smart labs and digital platforms, streamlining operations and enhancing patient care.
In December 2024, Suraksha completed its Initial Public Offering (IPO), raising ₹846.25 crore. The IPO was subscribed 1.27 times, reflecting strong investor confidence in the company's growth trajectory.
Suraksha-Diagnostics-launches-it-latest-centr-in-Bardhaman
.jpg)
0 Comments